Senior Healthcare Commercial Leader to Drive DistillerSR’s Managed Services Expansion
OTTAWA, Canada — September 22, 2026 — DistillerSR Inc., the pioneer and market leader in AI-enabled literature review automation and evidence management software, today announced the appointment of Glen Tinevez as Vice President of Solution Delivery. In this role, Glen will lead solution delivery at DistillerSR, expanding the company’s professional offering and deepening DistillerSR’s integration into customers’ clinical and AI technology ecosystems. Glen brings more than two decades of commercial leadership experience spanning diagnostics, medtech, and pharmaceuticals. He has held senior roles across sales, marketing, services, operations, and general management at leading organizations including Abbott, Cepheid, QuidelOrtho, and Thermo Fisher Scientific, as well as early-stage venture-backed companies such as Visby Medical. He also
served as a Principal at his advisory practice, where he worked with diagnostics and medtech companies, investors, and global health organizations on market entry, partnerships, and commercialization, including the Gates Foundation’s Women’s Health Innovations team, for which he developed a phased commercialization roadmap to expand access to new diagnostic technologies in low- and middle-income countries.
“Glen’s breadth of experience from early-stage ventures to some of the most recognized names in global healthcare makes him exceptionally well-suited to lead our solutions team at this stage of DistillerSR’s growth,” said Peter O’Blenis, CEO, DistillerSR Inc. “His track record of building high-performing commercial teams, expanding enterprise relationships, and delivering measurable customer outcomes is a great fit as we continue to scale our platform globally and deepen our partnerships with the world’s leading life sciences organizations.”
Glen holds a Bachelor of Business Administration from Washington State University and an associate degree from Mount Royal University, and has completed executive leadership programs at the Haas School of Business at the University of California, Berkeley, the University of Chicago Booth School of Business, and Queen’s University Smith School of Business.
About DistillerSR
DistillerSR’s AI-enabled systematic review and evidence management platform is used by researchers, healthcare organizations, and academic institutions worldwide to conduct literature reviews, meta-analyses, and evidence synthesis with greater efficiency and rigor. The company’s tools help research teams synthesize evidence more effectively, ultimately contributing to better-informed healthcare decisions and policies. DistillerSR is trusted by global research organizations, including more than 80% of the largest pharmaceutical and medical device companies, contract research organizations, governments, NGOs, and academic institutions.
Media Contact:
Vivian MacAdden
[email protected]
